Literature DB >> 22541695

Approach to a patient with elevated serum alkaline phosphatase.

Asma Siddique1, Kris V Kowdley.   

Abstract

Cholestasis develops either from a defect in bile synthesis, impairment in bile secretion, or obstruction to bile flow, and is characterized by an elevated serum alkaline phosphatase and gamma-glutamyltransferase disproportionate to elevation of aminotransferase enzymes. Key elements to the diagnostic workup include visualization of the biliary tree by cholangiography and evaluation of liver histology. The hope is that recent advances in understanding the genetic factors and immune mechanisms involved in the pathogenesis of cholestasis will lead to newer therapeutic interventions in the treatment of these diseases.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22541695      PMCID: PMC3341633          DOI: 10.1016/j.cld.2012.03.012

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  202 in total

1.  Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

Authors:  R Olsson; U Broomé; A Danielsson; I Hägerstrand; G Järnerot; L Lööf; H Prytz; B O Rydén
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis.

Authors:  Renée Eugénie Poupon; Keith D Lindor; Albert Parés; Olivier Chazouillères; Raoul Poupon; E Jenny Heathcote
Journal:  J Hepatol       Date:  2003-07       Impact factor: 25.083

Review 3.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 4.  Hepatobiliary transport.

Authors:  G A Kullak-Ublick; U Beuers; G Paumgartner
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

5.  Paroxetine in the treatment of severe non-dermatological pruritus: a randomized, controlled trial.

Authors:  Zbigniew Zylicz; Malgorzata Krajnik; Adriaan Alistar van Sorge; Massimo Costantini
Journal:  J Pain Symptom Manage       Date:  2003-12       Impact factor: 3.612

6.  A prospective study of 18 patients with cholestasis of pregnancy.

Authors:  D Shaw; J Frohlich; B A Wittmann; M Willms
Journal:  Am J Obstet Gynecol       Date:  1982-03-15       Impact factor: 8.661

7.  Choledochal cyst disease in children and adults: a 30-year single-institution experience.

Authors:  Barish H Edil; John L Cameron; Sushanth Reddy; Yingwei Lum; Pamela A Lipsett; Hari Nathan; Timothy M Pawlik; Michael A Choti; Christopher L Wolfgang; Richard D Schulick
Journal:  J Am Coll Surg       Date:  2008-03-17       Impact factor: 6.113

Review 8.  Diagnosis and management of acute cholangitis.

Authors:  John G Lee
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-08-04       Impact factor: 46.802

9.  Treatment of pruritus of primary biliary cirrhosis with rifampin.

Authors:  A Podesta; P Lopez; R Terg; F Villamil; D Flores; R Mastai; C B Udaondo; J P Companc
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

10.  Specific pruritic diseases of pregnancy. A prospective study of 3192 pregnant women.

Authors:  D Roger; L Vaillant; A Fignon; F Pierre; Y Bacq; J F Brechot; M C Grangeponte; G Lorette
Journal:  Arch Dermatol       Date:  1994-06
View more
  25 in total

Review 1.  Update in the Care and Management of Patients with Primary Sclerosing Cholangitis.

Authors:  Mai Sedki; Cynthia Levy
Journal:  Curr Gastroenterol Rep       Date:  2018-06-09

2.  Elevated Alkaline Phosphatase in a Cancer Patient: Think You Know the Source?

Authors:  Brittany L Carroll; Martin Fleisher; Melissa S Pessin; Lakshmi V Ramanathan
Journal:  J Appl Lab Med       Date:  2017-11-01

3.  Rhythmic Fluctuations in Levels of Liver Enzymes During Menstrual Cycles of Healthy Women and Effects of Body Weight.

Authors:  Chunwei Walter Lai; Sneha Jadhav; Basile Njei; Aijun Ye; Jean Wactawski-Wende; Sunni L Mumford; Enrique F Schisterman; Yaron Rotman
Journal:  Clin Gastroenterol Hepatol       Date:  2019-12-04       Impact factor: 11.382

Review 4.  A Systematic Approach to Patients with Jaundice.

Authors:  Bilal Gondal; Andrew Aronsohn
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

5.  Thrombocytopenia, anasarca, and severe inflammation.

Authors:  Amanallah Montazeripouragha; Christine M Campbell; James Russell; Nadia Medvedev; Daniel R Owen; Alison Harris; Fergal Donnellan; Iain McCormick; David C Fajgenbaum; Luke Y C Chen
Journal:  Am J Hematol       Date:  2022-07-19       Impact factor: 13.265

6.  Association between alendronate, serum alkaline phosphatase level, and heterotopic ossification in individuals with spinal cord injury.

Authors:  Avraam Ploumis; Jayne M Donovan; Mobolaji O Olurinde; Dana M Clark; Jason C Wu; Douglas J Sohn; Kevin C O'Connor
Journal:  J Spinal Cord Med       Date:  2014-05-13       Impact factor: 1.985

Review 7.  Primary biliary cirrhosis: Pathophysiology, clinical presentation and therapy.

Authors:  Treta Purohit; Mitchell S Cappell
Journal:  World J Hepatol       Date:  2015-05-08

8.  Significantly Elevated Liver Alkaline Phosphatase in Congestive Heart Failure.

Authors:  Leonid Shamban; Brijesh Patel; Michael Williams
Journal:  Gastroenterology Res       Date:  2014-05-02

9.  Ethanol extracts collected from the Styela clava tunic alleviate hepatic injury induced by carbon tetrachloride (CCl4) through inhibition of hepatic apoptosis, inflammation, and fibrosis.

Authors:  Eun Kyoung Koh; Ji Eun Kim; Sung Hwa Song; Ji Eun Sung; Hyun Ah Lee; Kil Soo Kim; Jin Tae Hong; Dae Youn Hwang
Journal:  J Toxicol Pathol       Date:  2017-08-28       Impact factor: 1.628

10.  Generation of monoclonal antibody MS17-57 targeting secreted alkaline phosphatase ectopically expressed on the surface of gastrointestinal cancer cells.

Authors:  Ming Li; Jianpeng Gao; Runhua Feng; Yuling Wang; Xuehua Chen; Jianyu Sun; Dongqing Zhang; Zhenggang Zhu; Lee M Ellis; Mason Lu; Jeffrey E Lee; Zhenqing Feng; Bingya Liu
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.